CH419127A - Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen - Google Patents

Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen

Info

Publication number
CH419127A
CH419127A CH152660A CH152660A CH419127A CH 419127 A CH419127 A CH 419127A CH 152660 A CH152660 A CH 152660A CH 152660 A CH152660 A CH 152660A CH 419127 A CH419127 A CH 419127A
Authority
CH
Switzerland
Prior art keywords
pyrrolidinols
substituted
preparation
Prior art date
Application number
CH152660A
Other languages
English (en)
Inventor
Hua Wu Yao
Frederick Feldkamp Rolland
Andrew Gould William
Original Assignee
Mead Johnson & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson & Co filed Critical Mead Johnson & Co
Publication of CH419127A publication Critical patent/CH419127A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
CH152660A 1959-02-12 1960-02-11 Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen CH419127A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79271259A 1959-02-12 1959-02-12
US2571A US3108117A (en) 1959-02-12 1960-01-15 3-benzyl-1, 2-diloweralkyl-3-pyrrolidinols

Publications (1)

Publication Number Publication Date
CH419127A true CH419127A (de) 1966-08-31

Family

ID=26670565

Family Applications (1)

Application Number Title Priority Date Filing Date
CH152660A CH419127A (de) 1959-02-12 1960-02-11 Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen

Country Status (6)

Country Link
US (1) US3108117A (de)
BE (1) BE587542A (de)
CH (1) CH419127A (de)
DE (1) DE1445100A1 (de)
FR (1) FR1310459A (de)
GB (1) GB882813A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821622B2 (ja) * 1973-02-28 1983-05-02 ウェルファイド株式会社 ピロリジンメタノ−ル ノ セイゾウホウ
EP0586229A1 (de) * 1992-09-01 1994-03-09 Zeneca Limited 3-Hydroxy-3-(Subst.-Alkyl)-Pyrrolidine als 5-Lipoxygenase-Inhibitoren
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
JP5489997B2 (ja) 2007-07-19 2014-05-14 シマベイ セラピューティクス, インコーポレーテッド 糖尿病および代謝疾患の治療のためのRUP3またはGPRl19受容体のアゴニストとしてのN−アザ環状置換ピロール、ピラゾール、イミダゾール、トリアゾールおよびテトラゾール誘導体
CN102203074A (zh) * 2008-06-20 2011-09-28 麦它波莱克斯股份有限公司 芳基gpr119激动剂及其用途
ES2497566T3 (es) 2009-10-01 2014-09-23 Cymabay Therapeutics, Inc. Sales de tetrazol-1-il-fenoximetil-tiazol-2-il-piperidinil-pirimidina sustituida
CN103037843A (zh) 2010-06-23 2013-04-10 麦它波莱克斯股份有限公司 5-乙基-2-{4-[4-(4-四唑-1-基-苯氧甲基)-噻唑-2-基]-哌啶-1-基}-嘧啶的组合物
CA3032432A1 (en) 2016-08-03 2018-02-08 Charles A. Mcwherter Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2878264A (en) * 1959-03-17 Substituted amino alcohols

Also Published As

Publication number Publication date
US3108117A (en) 1963-10-22
BE587542A (fr) 1960-08-12
GB882813A (en) 1961-11-22
DE1445100A1 (de) 1969-01-16
FR1310459A (fr) 1962-11-30

Similar Documents

Publication Publication Date Title
CH370197A (de) Verfahren zur Herstellung von Actinospectacin
CH387047A (de) Verfahren zur Herstellung von Ketosidopurinen
CH400144A (de) Verfahren zur Herstellung von 16-Methylen-17a-hydroxy-progesteron-17-acylaten
CH419127A (de) Verfahren zur Herstellung von substituierten 3-Pyrrolidinolen
CH404962A (de) Verfahren zur Herstellung von Eupolyoxymethylenen
CH396026A (de) Verfahren zur Herstellung von Halogenalkylaminen
CH387606A (de) Verfahren zur Herstellung von Tetrahydroxydibor
CH399742A (de) Verfahren zur Herstellung von Eupolyoxymethylenen
CH440249A (de) Verfahren zur Herstellung von Polychlorbenzonitrilen
CH382165A (de) Verfahren zur Herstellung substituierter Pyrrolidinole
CH416113A (de) Verfahren zur Herstellung von Eupolyoxymethylenen
CH417595A (de) Verfahren zur Herstellung von Alkyl-5-alkylisoxazol-3-carboxylaten
CH372297A (de) Verfahren zur Herstellung von 4-2-tert.-Aminomethyl-3-keto-steroiden
CH538458A (de) Verfahren zur Herstellung von a-Dithiosemicarbazonen
CH380730A (de) Verfahren zur Herstellung von 4-Methoxy-2-methyl-6-sulfanilamidopyrimidin
CH387029A (de) Verfahren zur Herstellung von 9a-Fluor-11B-oxy-16a-methylprogesteron
CH387048A (de) Verfahren zur Herstellung von 7-Theophyllinderivaten
CH400110A (de) Verfahren zur Herstellung von 2-Trifluormethylbenzhydrol
CH378344A (de) Verfahren zur Herstellung von 2-Amino-anthrachinonen
AT221092B (de) Verfahren zur Herstellung von substituierten 2-Oxo-benzochinolizinen
CH385849A (de) Verfahren zur Herstellung von substituierten 2-Oxobenzochinolizinen
AT217458B (de) Verfahren zur Herstellung von Chlorbenzonitrilen
AT241484B (de) Verfahren zur Herstellung von Glucofuranosiden
AT221103B (de) Verfahren zur Herstellung von Monoalkylphosphinen
AT221096B (de) Verfahren zur Herstellung von 2-Hydrazino-3-mercapto-chinoxalin